These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 17026576)
41. Use of the induced membrane technique for bone tissue engineering purposes: animal studies. Viateau V; Bensidhoum M; Guillemin G; Petite H; Hannouche D; Anagnostou F; Pélissier P Orthop Clin North Am; 2010 Jan; 41(1):49-56; table of contents. PubMed ID: 19931052 [TBL] [Abstract][Full Text] [Related]
42. Treatment of long bone defects and non-unions: from research to clinical practice. Berner A; Reichert JC; Müller MB; Zellner J; Pfeifer C; Dienstknecht T; Nerlich M; Sommerville S; Dickinson IC; Schütz MA; Füchtmeier B Cell Tissue Res; 2012 Mar; 347(3):501-19. PubMed ID: 21574059 [TBL] [Abstract][Full Text] [Related]
46. Animal models for bone tissue engineering and modelling disease. McGovern JA; Griffin M; Hutmacher DW Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29685995 [TBL] [Abstract][Full Text] [Related]
47. Cell sources for bone tissue engineering: insights from basic science. Colnot C Tissue Eng Part B Rev; 2011 Dec; 17(6):449-57. PubMed ID: 21902612 [TBL] [Abstract][Full Text] [Related]
48. The translation of product concept to bone products: a partnership of therapeutic effectiveness and commercialization. Ratcliffe A Tissue Eng Part B Rev; 2011 Dec; 17(6):443-7. PubMed ID: 21790510 [TBL] [Abstract][Full Text] [Related]
49. An overview of translational research in bone graft biomaterials. Kumawat VS; Bandyopadhyay-Ghosh S; Ghosh SB J Biomater Sci Polym Ed; 2023 Mar; 34(4):497-540. PubMed ID: 36124544 [TBL] [Abstract][Full Text] [Related]
50. Cell based advanced therapeutic medicinal products for bone repair: Keep it simple? Leijten J; Chai YC; Papantoniou I; Geris L; Schrooten J; Luyten FP Adv Drug Deliv Rev; 2015 Apr; 84():30-44. PubMed ID: 25451134 [TBL] [Abstract][Full Text] [Related]
51. [Supporting function of collagen and hydroxyapatite. Structure and function of bone]. Felsenberg D Pharm Unserer Zeit; 2001; 30(6):488-94. PubMed ID: 11715680 [No Abstract] [Full Text] [Related]
52. Tissue engineered models of healthy and malignant human bone marrow. Chramiec A; Vunjak-Novakovic G Adv Drug Deliv Rev; 2019 Feb; 140():78-92. PubMed ID: 31002835 [TBL] [Abstract][Full Text] [Related]
53. Intraoperative Creation of Tissue-Engineered Grafts with Minimally Manipulated Cells: New Concept of Bone Tissue Engineering In Situ. Krasilnikova OA; Baranovskii DS; Yakimova AO; Arguchinskaya N; Kisel A; Sosin D; Sulina Y; Ivanov SA; Shegay PV; Kaprin AD; Klabukov ID Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36421105 [TBL] [Abstract][Full Text] [Related]
54. Bone engineering: combining smart biomaterials and the application of stem cells. Lechner S; Huss R Artif Organs; 2006 Oct; 30(10):770-4. PubMed ID: 17026576 [TBL] [Abstract][Full Text] [Related]
55. Stem cells: potential therapy for age-related diseases. Kassem M Ann N Y Acad Sci; 2006 May; 1067():436-42. PubMed ID: 16804023 [TBL] [Abstract][Full Text] [Related]
56. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. Caplan AI J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285 [TBL] [Abstract][Full Text] [Related]